{"entity":{"type":"insider","cik":"0001753055","url":"/insider/0001753055","json_url":"/insider/0001753055.json","name":"Hickey Benjamin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":11,"first":"2021-01-08","last":"2025-05-13","span_basis":"filed_date"},"name_variants":[{"name":"Hickey Benjamin","source":"filing","n_filings":11,"first_seen":"2021-01-08","last_seen":"2025-05-13"}],"transactions":[{"id":4867433,"accession":"0000014272-25-000097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000014272-25-000097","line_url":"/filing/0000014272-25-000097#line-1","is_derivative":false,"issuer_cik":"0000014272","issuer_name":"BRISTOL MYERS SQUIBB CO","issuer_ticker":"BMY","issuer_name_source":null,"issuer_url":"/issuer/0000014272","owner_cik":"0001753055","owner_name":"Hickey Benjamin","owner_display_name":"Hickey Benjamin","owner_url":"/insider/0001753055","role":"Officer (President, RayzeBio Org)","role_mark":"O","role_mark_label":"Officer (President, RayzeBio Org)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, RayzeBio Org.","security_title":"Common Stock, $0.10 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":97.391,"shares_display":"97.39","price_per_share":38.01,"price_display":"38.01","price_state":"stated","total_value":3701.83191,"total_display":"3,701.83","total_whole":"3,702","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-09","filed_date":"2025-05-13","scope":"insider"},{"id":2363787,"accession":"0001628280-24-001696","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-24-001696","line_url":"/filing/0001628280-24-001696","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001753055","owner_name":"Hickey Benjamin","owner_display_name":"Hickey Benjamin","owner_url":"/insider/0001753055","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1597.0,"shares_display":"1,597","price_per_share":59.02,"price_display":"59.02","price_state":"stated","total_value":94254.94,"total_display":"94,254.94","total_whole":"94,255","shares_owned_after":117659.0,"shares_owned_after_display":"117,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-18","scope":"insider","n_lines":2},{"id":2829151,"accession":"0001628280-24-000977","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-000977","line_url":"/filing/0001628280-24-000977#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001753055","owner_name":"Hickey Benjamin","owner_display_name":"Hickey Benjamin","owner_url":"/insider/0001753055","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2090.0,"shares_display":"2,090","price_per_share":58.92,"price_display":"58.92","price_state":"stated","total_value":123142.8,"total_display":"123,142.80","total_whole":"123,143","shares_owned_after":118625.0,"shares_owned_after_display":"118,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-08","filed_date":"2024-01-09","scope":"insider"},{"id":8238553,"accession":"0001628280-23-041610","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-041610","line_url":"/filing/0001628280-23-041610#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001753055","owner_name":"Hickey Benjamin","owner_display_name":"Hickey Benjamin","owner_url":"/insider/0001753055","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2220.0,"shares_display":"2,220","price_per_share":56.67,"price_display":"56.67","price_state":"stated","total_value":125807.4,"total_display":"125,807.40","total_whole":"125,807","shares_owned_after":103694.0,"shares_owned_after_display":"103,694","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-13","filed_date":"2023-12-14","scope":"insider"},{"id":8610321,"accession":"0001214659-23-000808","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-23-000808","line_url":"/filing/0001214659-23-000808","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001753055","owner_name":"Hickey Benjamin","owner_display_name":"Hickey Benjamin","owner_url":"/insider/0001753055","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1566.0,"shares_display":"1,566","price_per_share":42.37928346104725,"price_display":"42.38","price_state":"stated","total_value":66365.9579,"total_display":"66,365.96","total_whole":"66,366","shares_owned_after":47842.0,"shares_owned_after_display":"47,842","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider","n_lines":2},{"id":7974572,"accession":"0001214659-23-000466","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-23-000466","line_url":"/filing/0001214659-23-000466#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001753055","owner_name":"Hickey Benjamin","owner_display_name":"Hickey Benjamin","owner_url":"/insider/0001753055","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2088.0,"shares_display":"2,088","price_per_share":45.37,"price_display":"45.37","price_state":"stated","total_value":94732.56,"total_display":"94,732.56","total_whole":"94,733","shares_owned_after":48789.0,"shares_owned_after_display":"48,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-10","scope":"insider"},{"id":6755557,"accession":"0001214659-22-015199","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-22-015199","line_url":"/filing/0001214659-22-015199#line-2","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001753055","owner_name":"Hickey Benjamin","owner_display_name":"Hickey Benjamin","owner_url":"/insider/0001753055","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3248.0,"shares_display":"3,248","price_per_share":40.4143,"price_display":"40.41","price_state":"stated","total_value":131265.6464,"total_display":"131,265.65","total_whole":"131,266","shares_owned_after":50877.0,"shares_owned_after_display":"50,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2022-12-21","scope":"insider"},{"id":6708593,"accession":"0001214659-22-000855","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-22-000855","line_url":"/filing/0001214659-22-000855#line-2","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001753055","owner_name":"Hickey Benjamin","owner_display_name":"Hickey Benjamin","owner_url":"/insider/0001753055","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":627.0,"shares_display":"627","price_per_share":120.4828,"price_display":"120.48","price_state":"stated","total_value":75542.7156,"total_display":"75,542.72","total_whole":"75,543","shares_owned_after":34976.0,"shares_owned_after_display":"34,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-18","filed_date":"2022-01-18","scope":"insider"},{"id":6931199,"accession":"0001214659-22-000471","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-22-000471","line_url":"/filing/0001214659-22-000471#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001753055","owner_name":"Hickey Benjamin","owner_display_name":"Hickey Benjamin","owner_url":"/insider/0001753055","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1964.0,"shares_display":"1,964","price_per_share":135.9389,"price_display":"135.94","price_state":"stated","total_value":266983.9996,"total_display":"266,984.00","total_whole":"266,984","shares_owned_after":24848.0,"shares_owned_after_display":"24,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-07","filed_date":"2022-01-07","scope":"insider"},{"id":5481264,"accession":"0001214659-21-003327","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001214659-21-003327","line_url":"/filing/0001214659-21-003327","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001753055","owner_name":"Hickey Benjamin","owner_display_name":"Hickey Benjamin","owner_url":"/insider/0001753055","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2369.0,"shares_display":"2,369","price_per_share":176.43630569860701,"price_display":"176.44","price_state":"stated","total_value":417977.6082,"total_display":"417,977.61","total_whole":"417,978","shares_owned_after":27243.0,"shares_owned_after_display":"27,243","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-19","filed_date":"2021-03-22","scope":"insider","n_lines":3},{"id":4289758,"accession":"0001214659-21-000338","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-21-000338","line_url":"/filing/0001214659-21-000338","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001753055","owner_name":"Hickey Benjamin","owner_display_name":"Hickey Benjamin","owner_url":"/insider/0001753055","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2078.0,"shares_display":"2,078","price_per_share":216.32556929740136,"price_display":"216.33","price_state":"stated","total_value":449524.533,"total_display":"449,524.53","total_whole":"449,525","shares_owned_after":19789.0,"shares_owned_after_display":"19,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-07","filed_date":"2021-01-08","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000014272","name":"BRISTOL MYERS SQUIBB CO","url":"/issuer/0000014272","role":"Officer (President, RayzeBio Org)","n_filings":1,"first_seen":"2025-05-13","last_seen":"2025-05-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001576263","name":"Mirati Therapeutics, Inc.","url":"/issuer/0001576263","role":"Officer (EVP, Chief Commercial Officer)","n_filings":10,"first_seen":"2021-01-08","last_seen":"2024-01-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001753055","retrieved_at":"2026-08-27T03:17:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}